5 Results for "

wild-type Mpro

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "wild-type Mpro" in MCE Product Catalog:

Cat. No.: HY-161777
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS-CoV-2 Mpro-IN-23 (Compound 2) is an inhibitor for SARS-CoV-2 main protease (Mpro), which inhibits wildtype Mpro and mutant Mpro variants, with IC50 of 0.057-0.92 μM. SARS-CoV-2 Mpro-IN-23 inhibits the post-entry viral processes of wild-type SARS-CoV-2 single-round infectious particles (SRIPs), suppresses the viral replication of Mpro wildtype and Mpro mutants with EC50 of 0.02-0.52 μM .
loading...
    loading...
Cat. No.: HY-181263
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

Jun13698 is a SARS-CoV-2 main protease (M pro) inhibitor with Ki values of 65.6 nM, 510.0 nM, and 117.5 nM against the wild-type, E166V, and E166A mutants, respectively. Jun13698 forms stable complexes with wild-type and mutant M pro to mediate enzyme inhibition. Jun13698 exhibits antiviral activity against SARS-CoV-2 variants carrying the E166V/A mutation. Jun13698 is applicable to COVID-19-related research .
loading...
    loading...
Cat. No.: HY-181249
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS-CoV-2 Mpro-IN-55 is a SARS-CoV-2 M pro inhibitor with a IC50 value of 7.20 nM. SARS-CoV-2 Mpro-IN-55 shows limited inhibitory activity against SARS-CoV-2. SARS-CoV-2 Mpro-IN-55 can be used in research related to COVID-19 .
loading...
    loading...
Cat. No.: HY-184146
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

AD05 is a SARS-CoV-2 main protease (M pro) inhibitor with an IC50 of 306.5 nM. AD05 exhibits antiviral activity against wild-type SARS-CoV-2 in host cells without inducing significant cytotoxicity. AD05 can be used in studies related to SARS-CoV-2 infection .
loading...
    loading...
Cat. No.: HY-184147
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

AD06 is a SARS-CoV-2 main protease (M pro) inhibitor with an IC50 of 163.3 nM. AD06 undergoes nucleophilic attack by deprotonated Cys145, thereby blocking viral replication. AD06 inhibits the activity of wild-type SARS-CoV-2 and shows no significant cytotoxicity in mammalian cells. AD06 can be used in studies related to SARS-CoV-2 infection .
loading...
    loading...